drugset / Trial / NCT02547870
A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the single-dose pharmacokinetics of rilpivirine (RPV) after intramuscular (IM) injection of rilpivirine long-acting parenteral formulation (RPV-LA) and 'aged' RPV-LA, in healthy adult participants.
Timeline
- Start
- 2015-08-14
- Primary completion
- 2016-04-26
- Completion
- 2016-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rilpivirine | Small molecule | 25 mg | Oral |
| Subject | Rilpivirine | Small molecule | 600 mg | Oral |